Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Market 2021-2031 by Product Type (API, FDF), Service Type (Preclinical, Clinical, Commercial), Customer Type (Pharmaceutical Firms, Biotechnology Firms), Therapeutic Area (Infectious Diseases, Oncology, Ophthalmology, Cardiovascular Disorders, Central Nervous System, Respiratory Disorders, Metabolic Diseases), and Region: Trend Forecast and Growth Opportunity

Global small molecule contract development and manufacturing organization (CDMO) market will reach $117,920.3 million by 2031, growing by 6.4% annually over 2021-2031, driven by the increasing demand for small molecule medicines and therapies, a rising demand for cost control in drug development, the increasing incidence of disease, and rising healthcare expenditures.
Highlighted with 83 tables and 84 figures, this 166-page report "Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Market 2021-2031 by Product Type (API, FDF), Service Type (Preclinical, Clinical, Commercial), Customer Type (Pharmaceutical Firms, Biotechnology Firms), Therapeutic Area (Infectious Diseases, Oncology, Ophthalmology, Cardiovascular Disorders, Central Nervous System, Respiratory Disorders, Metabolic Diseases), and Region: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire global small molecule contract development and manufacturing organization (CDMO) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global small molecule contract development and manufacturing organization (CDMO) market in every aspect of the classification from perspectives of Product Type, Service Type, Customer Type, Therapeutic Area, and Region.

Based on Product Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Active Pharmaceutical Ingredients (API)
o Branded Drugs
o Generic Drugs
• Finished Dosage Formulations (FDF)
o Oral Solid Drugs
o Injectable Drugs
o Semi-solid or Liquid Drugs
o Other FDFs

Based on Service Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Preclinical Use
• Clinical Use
o Phase I
o Phase II
o Phase III
o Phase IV
• Commercial Use

By Customer Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Pharmaceutical Firms
• Biotechnology Firms

By Therapeutic Area, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Infectious Diseases
• Oncology
• Ophthalmology
• Cardiovascular Disorders
• Central Nervous System
• Respiratory Disorders
• Metabolic Diseases
• Other Therapeutic Areas

Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE,Saudi Arabia, South Africa and Rest of MEA)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Product Type, Service Type and Therapeutic Area over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Boehringer Ingelheim
Cambrex Corporation
Catalent
Cipla
Covance Inc.
Lonza Group Ltd.
Medley Pharmaceuticals
NatcoPharma
Patheon (Thermo Fisher Scientific, Inc.)
Piramal Pharma Solutions
RedHillBiopharma
Siegfried Holding AG
STA Pharmaceutical
Sun Pharmaceutical
Teva
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 30
2.4 Emerging Opportunities and Market Trends 33
2.5 Porter's Fiver Forces Analysis 37
3 Segmentation of Global Market by Product Type 41
3.1 Market Overview by Product Type 41
3.2 Active Pharmaceutical Ingredients (API) 43
3.2.1 Branded Drugs 44
3.2.2 Generic Drugs 45
3.3 Finished Dosage Formulations (FDF) 46
3.3.1 Oral Solid Drugs 48
3.3.2 Injectable Drugs 49
3.3.3 Semi-solid or Liquid Drugs 50
3.3.4 Other FDFs 51
4 Segmentation of Global Market by Service Type 52
4.1 Market Overview by Service Type 52
4.2 Preclinical Use 54
4.3 Clinical Use 55
4.3.1 Phase I 57
4.3.2 Phase II 58
4.3.3 Phase III 59
4.3.4 Phase IV 60
4.4 Commercial Use 61
5 Segmentation of Global Market by Customer Type 62
5.1 Market Overview by Customer Type 62
5.2 Pharmaceutical Firms 64
5.3 Biotechnology Firms 65
6 Segmentation of Global Market by Therapeutic Area 66
6.1 Market Overview by Therapeutic Area 66
6.2 Infectious Diseases 68
6.3 Oncology 69
6.4 Ophthalmology 70
6.5 Cardiovascular Disorders 71
6.6 Central Nervous System 72
6.7 Respiratory Disorders 73
6.8 Metabolic Diseases 74
6.9 Other Therapeutic Areas 75
7 Segmentation of Global Market by Region 76
7.1 Geographic Market Overview 2021-2031 76
7.2 North America Market 2021-2031 by Country 80
7.2.1 Overview of North America Market 80
7.2.2 U.S. 84
7.2.3 Canada 87
7.2.4 Mexico 89
7.3 European Market 2021-2031 by Country 91
7.3.1 Overview of European Market 91
7.3.2 Germany 95
7.3.3 U.K. 97
7.3.4 France 99
7.3.5 Spain 101
7.3.6 Italy 103
7.3.7 Netherlands 105
7.3.8 Rest of European Market 107
7.4 Asia-Pacific Market 2021-2031 by Country 109
7.4.1 Overview of Asia-Pacific Market 109
7.4.2 Japan 113
7.4.3 China 116
7.4.4 Australia 118
7.4.5 India 120
7.4.6 South Korea 122
7.4.7 Rest of APAC Region 124
7.5 South America Market 2021-2031 by Country 126
7.5.1 Argentina 129
7.5.2 Brazil 131
7.5.3 Chile 133
7.5.4 Rest of South America Market 135
7.6 MEA Market 2021-2031 by Country 136
7.6.1 UAE 139
7.6.2 Saudi Arabia 141
7.6.3 South Africa 143
7.6.4 Other National Markets 145
8 Competitive Landscape 146
8.1 Overview of Key Vendors 146
8.2 New Product Launch, Partnership, Investment, and M&A 149
8.3 Company Profiles 150
Boehringer Ingelheim 150
Cambrex Corporation 152
Catalent 153
Cipla 154
Covance Inc. 155
Lonza Group Ltd. 156
Medley Pharmaceuticals 157
NatcoPharma 158
Patheon (Thermo Fisher Scientific, Inc.) 159
Piramal Pharma Solutions 160
RedHillBiopharma 161
Siegfried Holding AG 162
STA Pharmaceutical 163
Sun Pharmaceutical 164
Teva 165
RELATED REPORTS 166

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2023 Worldwide Market Reports. All Rights Reserved